Global Endometriosis Treatment Market Size & Outlook
Global endometriosis treatment market, 2018-2030 (US$M)
Related Markets
Global endometriosis treatment market highlights
- The global endometriosis treatment market generated a revenue of USD 1,222.2 million in 2022 and is expected to reach USD 3,229.1 million by 2030.
- The market is expected to grow at a CAGR (2023 - 2030) of 12.9% by 2030.
- In terms of segment, hormone therapy accounted for a revenue of USD 1,047.9 million in 2022.
- Hormone Therapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2022.
- Country-wise, Germany is expected to register the highest CAGR from 2023 to 2030.
Global data book summary
| Market revenue in 2022 | USD 1,222.2 million |
| Market revenue in 2030 | USD 3,229.1 million |
| Growth rate | 12.9% (CAGR from 2022 to 2030) |
| Largest segment | Hormone therapy |
| Fastest growing segment | Hormone Therapy |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pain Medication, Hormone Therapy |
Other key industry trends
- In terms of revenue, the North America accounted for 48.2% of the global endometriosis treatment market in 2022.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Germany is the fastest growing regional market and is projected to reach USD 149.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Endometriosis Treatment Market Scope
Endometriosis Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global endometriosis treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to endometriosis treatment market will help companies and investors design strategic landscapes.
Hormone therapy was the largest segment with a revenue share of 85.74% in 2022. Horizon Databook has segmented the Global endometriosis treatment market based on pain medication, hormone therapy covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Endometriosis Treatment Treatment Type Outlook (Revenue, USD Million, 2018-2030)
- Pain Medication
- Hormone Therapy
- Global Endometriosis Treatment Drug Class Outlook (Revenue, USD Million, 2018-2030)
- NSAIDs
- Oral Contraceptive
- Gonadotropin Releasing Hormone
- Others Drug Class
- Global Endometriosis Treatment Route Of Administration Outlook (Revenue, USD Million, 2018-2030)
- Oral
- Injectable
- Others Route Of Administration
- Global Endometriosis Treatment Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital Pharmacy
- Retail Pharmacy
- Others Distribution Channel
Reasons to subscribe to Global endometriosis treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global endometriosis treatment market databook
-
Our clientele includes a mix of endometriosis treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global endometriosis treatment market , including forecasts for subscribers. This global databook contains high-level insights into Global endometriosis treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global endometriosis treatment market report size, by regions, 2018-2030 (US$M)
Top 10 countries: Endometriosis treatment market report size, 2022 (US$M)
Global endometriosis treatment market report share, by treatment type, 2022 & 2030 (%, US$M)
Endometriosis treatment market: Opportunity assessment by country
Global endometriosis treatment market, by region, 2022 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
